2023
DOI: 10.1007/s11095-023-03530-z
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of Divergent Metabolic Pathways in Elucidating an Unexpected, Slow-Forming, and Long Half-Life Major Metabolite of Iclepertin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…This compound consists of 5‐methylsulfonyl‐2‐[(1 R )‐2,2,2‐trifluoro‐1‐methyl‐ethoxy]benzoic acid ( 2 ) linked via an amide bond to 3‐[(1 R ,5 R )‐3‐azabicyclo[3.1.0]hexan‐5‐yl]‐5‐(trifluoromethyl)isoxazole ( 3 ) (Figure 1). Iclepertin is metabolized in male human plasma, urine, and feces to at least 20 metabolites 2 . The structures of 11 of these metabolites were unequivocally determined.…”
Section: Introductionmentioning
confidence: 99%
“…This compound consists of 5‐methylsulfonyl‐2‐[(1 R )‐2,2,2‐trifluoro‐1‐methyl‐ethoxy]benzoic acid ( 2 ) linked via an amide bond to 3‐[(1 R ,5 R )‐3‐azabicyclo[3.1.0]hexan‐5‐yl]‐5‐(trifluoromethyl)isoxazole ( 3 ) (Figure 1). Iclepertin is metabolized in male human plasma, urine, and feces to at least 20 metabolites 2 . The structures of 11 of these metabolites were unequivocally determined.…”
Section: Introductionmentioning
confidence: 99%